🇺🇸 VTRS — Viatris Inc.

Healthcare
← Volver

Precio actual

16,88 USD

Máx. histórico

76,69

4151 días

Caída desde máximo

-77,99%

Rango 52 semanas

9,43 – 18,39

Variación hoy

-0,35%

Cierre anterior

16,94

Rango de hoy

16,67 – 17,02

Volumen hoy

5.599.203

Información
Nombre completo
Viatris Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - Specialty & Generic
Empleados
30.000
PER
Dividend yield
2,83% (puede no estar actualizado)
Precio objetivo analistas
18,50 USD (puede no estar actualizado)
Primera cotización
17/03/1980
Precio actualizado
hace 2 días
Sobre la empresa

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Dividendos repartidos Total últimos 12 meses: 0,4800 USD · Yield: 2,84%
Fecha de pago Importe por participación
22/11/2022 0,1200 USD
23/08/2022 0,1200 USD
23/05/2022 0,1200 USD
23/02/2022 0,1200 USD
22/11/2021 0,1100 USD
23/08/2021 0,1100 USD
21/05/2021 0,1100 USD
27/06/2007 0,0600 USD
28/03/2007 0,0600 USD
27/12/2006 0,0600 USD
27/09/2006 0,0600 USD
28/06/2006 0,0600 USD
29/03/2006 0,0600 USD
28/12/2005 0,0600 USD
28/09/2005 0,0600 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/03/2021 13,93 14,22 13,71 13,91 +0,58% 3,66% 10.908.800
08/03/2021 13,76 14,05 13,68 13,83 -0,58% 2,69% 11.899.600
05/03/2021 13,69 13,99 13,36 13,91 +2,35% 4,60% 13.295.300
04/03/2021 13,67 13,80 13,31 13,59 -2,09% 3,58% 18.720.700
03/03/2021 14,17 14,24 13,53 13,88 -2,87% 5,01% 24.164.100
02/03/2021 14,55 14,70 14,14 14,29 -2,92% 3,85% 16.236.600
01/03/2021 15,05 15,30 14,62 14,72 -0,88% 4,52% 11.907.400
26/02/2021 14,93 15,00 14,56 14,85 -1,33% 2,95% 15.769.600
25/02/2021 15,29 15,38 14,86 15,05 -1,63% 3,40% 16.272.400
24/02/2021 15,33 15,47 14,94 15,30 +0,53% 3,46% 15.465.600
23/02/2021 15,74 15,77 14,93 15,22 -1,81% 5,34% 21.414.400
22/02/2021 16,55 16,80 15,49 15,50 -14,88% 7,92% 39.361.600
19/02/2021 18,22 18,48 18,16 18,21 -0,33% 1,76% 10.868.900
18/02/2021 18,61 18,68 18,25 18,27 -1,35% 2,31% 6.811.400
17/02/2021 18,28 18,55 18,17 18,52 +0,98% 2,08% 4.683.800
16/02/2021 18,35 18,39 18,09 18,34 +0,55% 1,63% 5.009.000
12/02/2021 18,10 18,40 18,03 18,24 +0,00% 2,04% 4.469.300
11/02/2021 18,22 18,44 18,07 18,24 -0,82% 2,03% 5.498.100
10/02/2021 18,53 18,67 18,21 18,39 -0,43% 2,48% 7.291.000
09/02/2021 17,85 18,55 17,84 18,47 +2,61% 3,98% 6.575.100
08/02/2021 17,99 18,04 17,72 18,00 +0,56% 1,78% 7.331.800
05/02/2021 18,02 18,08 17,64 17,90 -0,56% 2,44% 7.864.600
04/02/2021 18,11 18,28 17,71 18,00 -0,50% 3,15% 7.266.600
03/02/2021 17,30 18,38 17,30 18,09 +4,09% 6,24% 15.935.500
02/02/2021 17,57 17,75 17,36 17,38 -0,40% 2,22% 9.194.000
01/02/2021 17,15 17,58 17,03 17,45 +2,71% 3,21% 8.954.900
29/01/2021 17,25 17,58 16,90 16,99 -1,16% 3,94% 8.256.100
28/01/2021 16,90 17,45 16,84 17,19 +1,96% 3,61% 9.215.200
27/01/2021 17,00 17,17 16,61 16,86 -1,35% 3,29% 14.517.700
26/01/2021 17,20 17,36 17,08 17,09 -0,81% 1,63% 5.968.700